Severe Clostridioides difficile infection can escalate to a fulminant presentation. This protocol covers management of that specific situation — when active infection is accompanied by hemodynamic compromise or intestinal dysfunction.
Severe C. difficile infection meeting criteria for fulminant disease: the patient presents with hypotension or hemodynamic shock, or with ileus or megacolon. This combination defines a distinct, high-acuity subset requiring a specific management approach.
Management of fulminant C. difficile infection includes urgent volume resuscitation alongside intensive antibiotic therapy. Additional interventions may be layered depending on the specific complication present.
Key target: Clinical improvement within the first treatment window guides subsequent decisions about therapy adjustment.
Full regimen, dosing strategy, route-specific measures, and stepdown criteria are available in the complete protocol →
DOI: 10.14309/ajg.0000000000001278
We recommend defining fulminant infection as patients meeting criteria for severe C. difficile infection plus presence of hypotension or shock or ileus or megacolon.
Patients with fulminant CDI should receive medical therapy that includes adequate volume resuscitation and treatment with 500 mg of oral vancomycin every 6 hours daily (strong recommendation, very low quality of evidence) for the first 48–72 hours.
Combination therapy with parenteral metronidazole 500 mg every 8 hours can be considered (conditional recommendation, very low quality of evidence).
For patients with an ileus, the addition of vancomycin enemas (500 mg every 6 hours) may be beneficial (conditional recommendation, very low quality of evidence).
Thereafter, in the case of clinical improvement, the dose should be decreased to 125 mg every 6 hours and continued for an additional 10 days.
View source ↗